Garivulimab (Anti-B7-H1 / PD-L1 / CD274), 1mg*5

Garivulimab (Anti-B7-H1 / PD-L1 / CD274), 1mg*5

Befovacimab (Anti-TFPI), 1mg

Befovacimab (Anti-TFPI), 1mg

Garivulimab (Anti-B7-H1 / PD-L1 / CD274), 1mg*25

32.845,19 RON
SKU
SKM_A2778_1mg*25

Garivulimab (Anti-B7-H1 / PD-L1 / CD274) is a humanized immunoglobulin G1 (IgG1)-variant monoclonal antibody directed against the immunosuppressive ligand programmed cell death-1 ligand 1 (PD-L1; cluster of differentiation 274; CD274), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 144.3 KD.

Mai multe informatii
Price 27.601,00 RON (preturile sunt fara TVA)
Description

Garivulimab (Anti-B7-H1 / PD-L1 / CD274) is a humanized immunoglobulin G1 (IgG1)-variant monoclonal antibody directed against the immunosuppressive ligand programmed cell death-1 ligand 1 (PD-L1; cluster of differentiation 274; CD274), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 144.3 KD.